Biotest AG
XETRA:BIO2
Biotest AG
XETRA:BIO2
Price:
43.02
EUR
Market Cap:
€1.7B
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIO2's stock price target?
Not Available
BIO2 doesn't have any price targets made by Wall Street professionals.
What is Biotest AG's Revenue forecast?
Projected CAGR
-1%
-1%
For the last 8 years the
compound annual growth rate for
Biotest AG's revenue is
7%.
The projected
CAGR
for the next 1 year is
-1%.
What is Biotest AG's Operating Income forecast?
Projected CAGR
25%
25%
For the last 8 years the
compound annual growth rate for
Biotest AG's operating income is
12%.
The projected
CAGR
for the next 1 year is
25%.
What is Biotest AG's Net Income forecast?
Projected CAGR
121%
121%
The
compound annual growth rate
of Biotest AG's net income for the next 1 year is
121%.
